Hark Capital has closed a $50 million NAV facility with Pharos IV-A, L.P. to support healthcare investments focused on improving patient care and access.

Information on the Target

Pharos IV-A, L.P. is a middle-market private equity fund operated by Pharos Capital Group, specializing in healthcare companies. The firm is dedicated to enhancing patient care experiences, increasing healthcare access for underserved populations, and reducing overall healthcare costs. The recently closed $50 million NAV facility will serve to support both existing and new investments within Pharos’ healthcare portfolio.

Industry Overview in the Target’s Specific Country

The healthcare industry in the United States has been undergoing significant transformations, particularly with a growing emphasis on patient-centered care and cost reduction. The sector has seen increased investment focusing on innovative solutions that address healthcare challenges, from accessibility in rural areas to enhancing the quality of service delivery in urban settings.

Market trends indicate that investment firms are actively seeking opportunities within the healthcare domain that align with social impact, particularly in terms of improv